I believe the BARDA proposal only dealt with radiation, it's rejection may have been based on the needs they saw coming with coronavirus, and funding that said they can't have everything they want. It's been pointed out that they have a new solicitation going, and PSTI should certainly submit.
Personally, I believe it takes too long for BARDA to act, especially if no data exists on what you're proposing. If I were the company, working in Israel and any other country willing to do a trial without a lot of red tape involved, I'd do so as quickly as I could. If something like 25 patients with serious pneumonia could be tested without blinding the trial, so benefits could immediately be seen, within a month or so you'd have a result that either said it was worthy of being expanded on, or not.
I'm not sure that if we could prove the benefit in 25 people that some countries wouldn't want to employ it immediately, remember, our drugs have been through safety trials, so they're know to be safe. If a small number of people clearly improve, why not get it out there and see if it benefits many more.
Gary
News 
Market Data 
Discover 
AI
